Skip to main content
Journal cover image

A multidisciplinary opioid-reduction pathway for robotic prostatectomy: outcomes at year one.

Publication ,  Journal Article
Manning, MW; Whittle, J; Fuller, M; Cooper, SH; Manning, EL; Chapman, J; Moul, JW; Miller, TE
Published in: Perioper Med (Lond)
August 1, 2023

BACKGROUND: Opioid use has come under increasing scrutiny, driven in part by the opioid crisis and growing concerns that up to 6% of opioid-naïve patients may become chronic opioid users. This has resulted in a revaluation of perioperative practice. For this reason, we implemented a multidisciplinary pathway to reduce perioperative opioid usage through education and standardization of practice. METHODS: A single-centre retrospective evaluation was performed after 1 year, comparing the outcomes to those of the 2 years prior to pathway implementation. Comparisons were made between pre- vs. post pathway change by 2:1 propensity matching between cohorts. Univariate linear regression models were created using demographic variables with those that were p < 0.15 included in the final model and using post-operative opioid use (in oral morphine equivalents, OME) as the primary outcome. RESULTS: We found that intraoperative opioid use was significantly decreased 38.2 mg (28.3) vs. 18.0 mg (40.4) oral morphine equivalents (OME), p < .001, as was post-operative opioid use for the duration of the hospitalization, 46.3 mg (49.5) vs. 35.49 mg (43.7) OME, p = 0.002. In subgroup analysis of those that received some intraoperative opioids (n = 152) and those that received no opioids (n = 34), we found that both groups required fewer opioids in the post-operative period 47.0 mg (47.7) vs. 32.4 mg (40.6) OME, p = 0.001, + intraoperative opioids, 62.4 mg (62.9) vs. 35.8 mg (27.7) OME, p = 0.13, - intraoperative opioids. Time to discharge from the PACU was reduced in both groups 215 min (199) vs. 167 min (122), p < 0.003, + intraoperative opioids and 253 min (270) vs. 167 min (105), p = 0.028, - intraoperative opioids. The duration of time until meeting discharge criteria from PACU was 221 min (205) vs. 170 min (120), p = 0.001. Hospital length of stay (LOS) was significantly reduced 1.4 days (1.3) vs. 1.2 days (0.8), p = 0.005. Both sub-groups demonstrated reduced hospital LOS 1.5 days (1.4) vs. 1.2 days (0.8), p = 0.0047, + intraoperative opioids and 1.7 days (1.6) vs. 1.3 days (0.9), p = 0.0583, - intraoperative opioids. Average pain scores during PACU admission and post-PACU until discharge were not statistically different between cohorts. CONCLUSIONS: These findings underscore the effectiveness of a multidisciplinary approach to reduce opioids. Furthermore, it demonstrates improved patient outcomes as measured by both shorter PACU and almost 50% reduction in perioperative opioid use whilst maintaining similar analgesia as indicated by patient-reported pain scores.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Perioper Med (Lond)

DOI

ISSN

2047-0525

Publication Date

August 1, 2023

Volume

12

Issue

1

Start / End Page

43

Location

England

Related Subject Headings

  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Manning, M. W., Whittle, J., Fuller, M., Cooper, S. H., Manning, E. L., Chapman, J., … Miller, T. E. (2023). A multidisciplinary opioid-reduction pathway for robotic prostatectomy: outcomes at year one. Perioper Med (Lond), 12(1), 43. https://doi.org/10.1186/s13741-023-00331-1
Manning, Michael W., John Whittle, Matthew Fuller, Sara H. Cooper, Erin L. Manning, Joe Chapman, Judd W. Moul, and Timothy E. Miller. “A multidisciplinary opioid-reduction pathway for robotic prostatectomy: outcomes at year one.Perioper Med (Lond) 12, no. 1 (August 1, 2023): 43. https://doi.org/10.1186/s13741-023-00331-1.
Manning MW, Whittle J, Fuller M, Cooper SH, Manning EL, Chapman J, et al. A multidisciplinary opioid-reduction pathway for robotic prostatectomy: outcomes at year one. Perioper Med (Lond). 2023 Aug 1;12(1):43.
Manning, Michael W., et al. “A multidisciplinary opioid-reduction pathway for robotic prostatectomy: outcomes at year one.Perioper Med (Lond), vol. 12, no. 1, Aug. 2023, p. 43. Pubmed, doi:10.1186/s13741-023-00331-1.
Manning MW, Whittle J, Fuller M, Cooper SH, Manning EL, Chapman J, Moul JW, Miller TE. A multidisciplinary opioid-reduction pathway for robotic prostatectomy: outcomes at year one. Perioper Med (Lond). 2023 Aug 1;12(1):43.
Journal cover image

Published In

Perioper Med (Lond)

DOI

ISSN

2047-0525

Publication Date

August 1, 2023

Volume

12

Issue

1

Start / End Page

43

Location

England

Related Subject Headings

  • 3202 Clinical sciences